A detailed history of Plato Investment Management LTD transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Plato Investment Management LTD holds 90 shares of BHC stock, worth $847. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90
Holding current value
$847
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$5.22 - $8.26 $469 - $743
90 New
90 $735,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $3.41B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Plato Investment Management LTD Portfolio

Follow Plato Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plato Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Plato Investment Management LTD with notifications on news.